UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045397
Receipt number R000051810
Scientific Title Investigate the relationship between the individual differences in the effects of continuous ubiquinol (reduced CoQ10) supplementation on improving QOL and cognitive function and the single nucleotide polymorphisms in CoQ10 metabolism-related genes.
Date of disclosure of the study information 2021/09/07
Last modified on 2022/09/07 09:13:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigate the relationship between the individual differences in the effects of continuous ubiquinol (reduced CoQ10) supplementation on improving QOL and cognitive function and the single nucleotide polymorphisms in CoQ10 metabolism-related genes.

Acronym

Investigation of the relationship between the individual differences in the effects of continuous ubiquinol supplementation on improving QOL and cognitive function and the single nucleotide polymorphisms.

Scientific Title

Investigate the relationship between the individual differences in the effects of continuous ubiquinol (reduced CoQ10) supplementation on improving QOL and cognitive function and the single nucleotide polymorphisms in CoQ10 metabolism-related genes.

Scientific Title:Acronym

Investigation of the relationship between the individual differences in the effects of continuous ubiquinol supplementation on improving QOL and cognitive function and the single nucleotide polymorphisms.

Region

Japan


Condition

Condition

Nothing

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

It was found that the increased serum CoQ10 levels after continuous ubiquinol supplementation were affected by the single nucleotide polymorphisms (SNP) in the participants of the "Verification of health enhancement and QOL improvement effect by continuous ubiquinol ingestion (Ubiquinol Health Examination)" study (UMIN000012612). These SNPs are involved in CoQ10 and cholesterol metabolism/absorption-related genes.
This project aimed to search for the involvement of the above SNPs in the QOL- and cognitive function-improvement by ubiquinol supplementation.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Relationship between SNPs and SF-36 by the continuous ubiquinol supplementation

Key secondary outcomes

Relationship between SNPs and Digit Symbol Substitution Test by the continuous ubiquinol supplementation


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

One hundred seventy people participated in the "Relationship between the absorption of ubiquinol supplement and the genetic diversity for participants in the Ubiquinol Health Examination (SNP Study)" (2016) and in the Ubiquinol Health Examination (from 2013 to 2018). The SNP Study was approved by the Wayo Women's University Human Research Ethics Committee (No. 1614).

Key exclusion criteria

Those who were assessed to have a low intake rate of ubiquinol supplement based on serum CoQ10 levels in this study

Target sample size

170


Research contact person

Name of lead principal investigator

1st name Toshikazu
Middle name
Last name Suzuki

Organization

Wayo Women's University

Division name

Department of Health and Nutrition

Zip code

272-8533

Address

Konodai 2-3-1, Ichikawa, Chiba

TEL

043-371-1547

Email

t-suzuki@wayo.ac.jp


Public contact

Name of contact person

1st name Toshikazu
Middle name
Last name Suzuki

Organization

Wayo Women's University

Division name

Department of Health and Nutrition

Zip code

272-8533

Address

Konodai 2-3-1, Ichikawa, Chiba

TEL

043-371-1547

Homepage URL

https://wayonutrsuzukilab.wixsite.com/biochem

Email

t-suzuki@wayo.ac.jp


Sponsor or person

Institute

Wayo Women's University

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Institute of Community Life Sciences Co., Ltd.
Kaneka Co.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Wayo Women's University Human Research Ethics Committee

Address

2-3-1 Konodai, Ichikawa, Chiba

Tel

047-371-1184

Email

k-shien@wayo.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

2102-2

Org. issuing International ID_1

Wayo Women's University Human Research Ethics Committee

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 09 Month 07 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://doi.org/10.3390/nu14132579

Number of participants that the trial has enrolled

170

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2021 Year 08 Month 18 Day

Date of IRB

2021 Year 09 Month 03 Day

Anticipated trial start date

2021 Year 09 Month 07 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry

2022 Year 03 Month 31 Day

Date trial data considered complete

2022 Year 03 Month 31 Day

Date analysis concluded

2022 Year 06 Month 20 Day


Other

Other related information

This project is a retrospective study using the existing database and an opt-out recruitment method. We release information about this project on the websites of our laboratory and Institute of Community Life Sciences Co., Ltd. to allow declining participation in this study to the candidates.


Management information

Registered date

2021 Year 09 Month 06 Day

Last modified on

2022 Year 09 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051810


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name